Why Is Cancer Immunotherapy-Focused Compugen Stock Is Trading Higher Today? - Compugen (NASDAQ:CGEN)
Gilead Sciences Inc (NASDAQ: GILD) announced an agreement with Compugen Ltd (NASDAQ: CGEN) to license its pre-clinical antibody program against IL-18 binding protein exclusively, including the